Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Recently, an increasing number of novel drugs were approved in oncology and hematology. Nevertheless, pharmacology progress comes with a variety of side effects, of which cytokine release syndrome (CRS) is a potential complication of some immunotherapies that can lead to multiorgan failure if not di...

Full description

Saved in:
Bibliographic Details
Main Authors: Hermann Einsele, Anca Colita, Dana Tomescu, Sabina Iluta, Sergiu Pasca, Delia Dima, Ciprian Tomuleasa, Catalin Vlad, Catalin Constantinescu, Tiberiu Tat, Patric Teodorescu, Ecaterina Scarlatescu, Alina Tanase, Olafur Eysteinn Sigurjonsson
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000742.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/8/1/e000742.full

Similar Items